|
|
|
|
Effect of Carbamazepine (CBZ) on Dolutegravir (DTG) Pharmacokinetics
|
|
|
Reported by Jules Levin
ICAAC - 54th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 5-9, 2014; Washington, DC
S Weller,1 J Borland,1 B Wynne,2 M Choukour,3 F Jerva,1 L Webster,1 S Piscitelli,1 I Song1
1GlaxoSmithKline, Research Triangle Park, NC; 2GlaxoSmithKline, Upper Providence, PA; 3Parexel Inc, Billerica, MA
|
|
|
|
|
|
|